Wegovy-maker Novo Nordisk said on Thursday it had told all its staff to return to the office as the drugmaker's new CEO tries ...

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

The Danish drugmaker said it needed to streamline operations and become more agile, as it faces a more competitive and ...

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

Novo Nordisk said the job cuts will eliminate about 11% of its workforce, with 5,000 of the reductions in Denmark.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

The Novo Nordisk RTO mandate could be a strategy to encourage attrition, but if community-building is the goal, additional ...